Ligand Pharmaceuticals | LGND - EPS Earnings Per Share

Stock Price
191.74
Daily Change
2.74 1.45%
Monthly
-3.27%
Yearly
66.72%
Q1 Forecast
178.28

Ligand Pharmaceuticals reported $3.09 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 1.49 1.27 Feb/26 2026
FY2025Q3 Sep/2025 3.09 1.93 1.84 Nov/06 2025
FY2025Q2 Jun/2025 1.60 1.43 1.40 Aug/07 2025
FY2025Q1 Mar/2025 1.33 1.22 1.20 May/08 2025
FY2024Q4 Dec/2024 1.27 1.18 1.05 Feb/27 2025




Eps Change Date
Agenus USD -1.03 1.01 Mar/2025
Amgen USD 5.29 0.35 Dec/2025
Anika Therapeutics USD -0.34 1.16 Mar/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
Baxter International USD 0.44 0.25 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Enviri Corporation USD -1.05 0.89 Dec/2024
Gilead Sciences USD 1.86 0.61 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Glaxosmithkline GBP 0.72 0.37 Sep/2025
Heron Therapeutics USD -0.03 0.03 Sep/2024
Insmed USD -1.54 0.21 Dec/2025
Intrexon USD -0.1 0.03 Jun/2024
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Ligand Pharmaceuticals USD 3.09 1.49 Sep/2025
MacroGenics USD 0.27 0.84 Sep/2025
Merck USD 2.04 0.54 Dec/2025
Pacira USD 0.7 0.04 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Veracyte USD 0.51 0.07 Sep/2025